Alpine immune sciences, inc. (ALPN)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Dec'14
Assets
Current assets:
Cash and cash equivalents

24,446

16,123

17,395

15,468

41,437

10,711

11,473

3,569

7,446

8,000

11,982

27,548

12,929

11,819

16,168

15,416

16,030

24,991

57,555

100,521

27,812

Short-term investments

11,237

24,397

29,193

40,097

22,519

41,592

-

-

-

73,240

-

-

-

-

-

-

-

-

-

-

-

Restricted cash, current

132

132

132

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

-

-

-

-

50,509

66,376

69,206

-

75,219

-

39,745

-

-

-

-

62,263

-

-

-

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

21,949

-

-

50,019

58,318

64,182

-

35,096

-

-

Prepaid Expense and Other Assets, Current

2,273

1,650

5,734

1,657

939

1,242

1,098

1,850

1,335

1,308

884

129

263

36

843

480

501

432

996

569

630

Total current assets

38,088

42,302

52,454

57,222

64,895

53,545

63,080

71,795

77,987

82,548

88,085

49,626

52,937

11,855

67,030

74,214

80,713

87,686

93,647

101,090

28,442

Restricted cash, noncurrent

254

254

254

386

386

132

132

132

132

132

132

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

1,669

1,552

1,201

1,176

1,221

1,196

1,296

1,197

1,127

1,089

1,116

-

-

740

-

-

-

-

-

-

-

Operating lease, right-of-use asset

9,838

9,985

10,800

11,300

603

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets

-

-

-

-

-

-

0

0

1,453

1,453

1,453

-

-

-

-

-

-

-

-

-

-

Property and equipment and other assets, net

-

-

-

-

-

-

-

-

-

-

-

18

72

-

312

351

224

223

195

157

101

Total assets

49,849

54,093

64,739

70,087

67,105

54,873

64,508

73,124

80,699

85,222

90,786

49,644

53,009

12,595

67,342

74,565

80,937

87,909

93,842

101,247

28,543

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

468

1,543

5,778

2,399

743

1,716

440

750

528

193

1,076

815

1,278

127

1,012

2,110

1,196

994

1,552

3,432

929

Accrued liabilities

2,551

5,285

5,825

5,518

5,371

4,363

4,314

585

586

382

642

-

-

170

-

-

-

-

-

-

-

Deferred revenue

344

1,435

2,069

2,108

-

0

0

0

-

277

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, current portion

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability, current

-

-

-

452

670

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes payable

-

-

-

-

-

-

-

-

-

-

67

-

-

66

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

240

-

405

-

-

2,008

-

-

-

-

-

-

-

Deferred rent, current portion

-

-

-

-

-

-

79

73

66

48

44

-

-

33

-

-

-

-

-

-

-

Current portion of long-term debt

1,742

418

0

2,079

2,064

2,048

2,034

2,018

1,508

995

490

-

-

-

-

-

-

-

-

-

-

Accrued direct program expenses

-

-

-

-

-

-

-

-

-

-

-

8

87

-

2,837

2,742

2,609

1,555

1,457

1,682

1,244

Accrued restructuring charges

-

-

-

-

-

-

-

-

-

-

-

2,584

2,251

-

-

-

-

-

-

-

-

Accrued employee benefits

-

-

-

-

-

-

-

-

-

-

-

146

119

-

1,345

985

712

1,675

1,336

977

210

Accrued other liabilities

-

-

-

-

-

-

-

-

-

-

-

25

54

-

44

36

61

195

120

32

32

Total current liabilities

5,105

8,681

13,672

12,556

8,848

8,127

6,867

3,426

2,928

1,895

2,724

3,578

3,789

2,404

5,238

5,873

4,578

4,419

4,465

6,123

2,415

Operating lease liability, noncurrent

11,716

11,429

11,350

10,919

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, long-term portion

-

-

-

-

-

-

26

47

67

66

81

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

0

-

-

305

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

0

253

-

509

-

-

-

-

-

-

-

-

-

-

Long-term debt

8,169

4,509

4,886

1,191

1,674

2,155

2,631

3,104

3,570

4,039

4,500

-

-

113

-

-

-

-

-

-

-

Total liabilities

24,990

24,619

29,908

24,666

10,522

10,282

9,524

6,577

6,818

6,305

7,814

-

-

2,517

-

-

-

-

-

-

-

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

Convertible preferred stock, $0.001 par value per share; 10,000,000 shares authorized at December 31, 2019 and 2018; zero shares issued and outstanding at December 31, 2019 and 2018

-

-

-

-

-

0

0

0

0

0

-

-

-

11,535

-

-

-

-

-

-

41,880

Stockholders’ equity:
Common stock, $0.001 par value per share; 200,000,000 shares authorized at March 31, 2020 and December 31, 2019; 18,638,359 shares issued and 18,587,892 shares outstanding at March 31, 2020; 18,638,359 shares issued and 18,587,892 shares outstanding at December 31, 2019

19

19

19

19

19

14

14

14

14

14

1

-

-

-

-

-

-

-

-

-

-

Treasury stock, at cost; 50,467 shares at March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Preferred stock, $0.001 par value; 10,000,000 shares authorized and no shares issued and outstanding for both periods presented

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

Common stock, $0.001 par value; 200,000,000 shares authorized for both periods presented; 15,656,251 and 15,565,973 shares issued and outstanding, respectively

-

-

-

-

-

-

-

-

-

-

-

16

16

-

16

15

15

15

15

15

2

Additional paid-in capital

118,417

117,371

116,591

115,704

115,031

90,664

89,933

89,387

88,864

88,346

88,049

238,980

238,434

144

234,670

233,808

233,016

232,309

231,621

231,294

110,265

Accumulated other comprehensive loss

-

-

-

-

-

-

-25

-55

-105

-

-12

-

-

-

-

-

-

-

-

-

-

Accumulated other comprehensive gain (loss)

-118

10

7

9

-12

-13

-

-

-

-59

-

-4

-14

-

5

23

3

3

15

-

-

Accumulated deficit

-93,459

-87,926

-81,786

-70,311

-58,455

-46,074

-34,938

-22,799

-14,892

-9,384

-5,066

-192,926

-189,216

-1,601

-172,587

-165,154

-156,675

-148,837

-142,274

-136,185

-126,019

Total stockholders’ equity

24,859

29,474

34,831

45,421

56,583

44,591

54,984

66,547

73,881

78,917

82,972

46,066

49,220

-1,457

62,104

68,692

76,359

83,490

89,377

95,124

-15,752

Total liabilities and stockholders’ equity

49,849

54,093

64,739

70,087

67,105

54,873

64,508

73,124

80,699

85,222

90,786

49,644

53,009

12,595

67,342

74,565

80,937

87,909

93,842

101,247

28,543